Navigating the fine line between benefit and risk in chronic atrial fibrillation: Rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY)

Date

2011

Authors

Carrington, Melinda
Ball, Jocasta
Horowitz, John D.
Marwick, Thomas H.
Mahadevan, Gnanadevan
Wong, Chiew
Abhayaratna, Walter
Haluska, Brian
Thompson, David R
Scuffham, Paul A

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

Background: Health outcomes associated with atrial fibrillation (AF) continue to be poor and standard management often does not provide clinical stability. The Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY) compares the efficacy of

Description

Keywords

Keywords: warfarin; anticoagulant therapy; article; cost effectiveness analysis; event free survival; heart atrium fibrillation; high risk patient; home care; hospital patient; hospital readmission; multicenter study (topic); priority journal; prospective study; ra Anti-coagulation; Atrial fibrillation; Disease management

Citation

Source

International Journal of Cardiology

Type

Journal article

Book Title

Entity type

Access Statement

License Rights

DOI

10.1016/j.ijcard.2011.10.065

Restricted until

2037-12-31